Louisiana ASC 1st in country to implant Biotronik’s ultrathin, drug-eluting stent

A Houma, La.-based practice became the first ASC in the country to implant Biotronik’s Orsiro Mission coronary artery drug eluting stent. 

Advertisement

The procedure to treat coronary artery disease was performed Jan. 7 at Cardiovascular Institute of the South’s ASC in Gray, La., the center said Jan. 19. 

The stent system is designed to ease the opening of lesions and restore blood flow to the coronary arteries. The Orsiro Mission features a drug-eluting stent with an ultrathin strut design, considered to be the thinnest available in the U.S.

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Cardiology

  • Cardiology is expanding increasingly into ASCs as CMS policy updates, advancements in cardiovascular innovation and population health concerns necessitate more…

  • As more cardiac procedures move into the ambulatory setting, developers are taking different approaches to what that shift should look…

Advertisement

Comments are closed.